theobromine has been researched along with Arterial Occlusive Diseases in 59 studies
Theobromine: 3,7-Dimethylxanthine. The principle alkaloid in Theobroma cacao (the cacao bean) and other plants. A xanthine alkaloid that is used as a bronchodilator and as a vasodilator. It has a weaker diuretic activity than THEOPHYLLINE and is also a less powerful stimulant of smooth muscle. It has practically no stimulant effect on the central nervous system. It was formerly used as a diuretic and in the treatment of angina pectoris and hypertension. (From Martindale, The Extra Pharmacopoeia, 30th ed, pp1318-9)
theobromine : A dimethylxanthine having the two methyl groups located at positions 3 and 7. A purine alkaloid derived from the cacao plant, it is found in chocolate, as well as in a number of other foods, and is a vasodilator, diuretic and heart stimulator.
Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effects of pentoxifylline on intermittent claudication were evaluated at a dose of 1200 mg/day in an open-label twelve-week study on geriatric patients with chronic occlusive arterial disease (COAD)." | 9.06 | Efficacy and safety of pentoxifylline in geriatric patients with intermittent claudication. ( Cobert, BL; Cohn, JB; Crowder, JE; Hryniewicki, SW; Morgan, DL; Piccirillo, RT; Savitsky, JP; Slywka, J; Wilcox, CS, 1989) |
| "Ten patients with Stage II chronic arterial occlusive disease (intermittent claudication) took part in a randomized, intraindividual crossover study involving acute intravenous administration of 200 mg pentoxifylline or physiological saline solution (placebo)." | 9.06 | Influence of pentoxifylline on muscle tissue oxygen tension (pO2) of patients with intermittent claudication before and after pedal ergometer exercise. ( Ehrly, AM; Saeger-Lorenz, K, 1987) |
| "The effects of pentoxifylline on intermittent claudication were evaluated at a dose of 1200 mg/day in an open-label twelve-week study on geriatric patients with chronic occlusive arterial disease (COAD)." | 5.06 | Efficacy and safety of pentoxifylline in geriatric patients with intermittent claudication. ( Cobert, BL; Cohn, JB; Crowder, JE; Hryniewicki, SW; Morgan, DL; Piccirillo, RT; Savitsky, JP; Slywka, J; Wilcox, CS, 1989) |
| "Ten patients with Stage II chronic arterial occlusive disease (intermittent claudication) took part in a randomized, intraindividual crossover study involving acute intravenous administration of 200 mg pentoxifylline or physiological saline solution (placebo)." | 5.06 | Influence of pentoxifylline on muscle tissue oxygen tension (pO2) of patients with intermittent claudication before and after pedal ergometer exercise. ( Ehrly, AM; Saeger-Lorenz, K, 1987) |
| "Pentoxifylline was significantly more effective than the placebo in increasing both the initial and absolute claudication distance (ICD and ACD) in patients with peripheral chronic occlusive arterial disease (COAD)." | 3.76 | Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease. ( Aggarwal, KK; Chopra, HK; Chopra, KL; Parashar, SK, 1988) |
| " infusion of pentoxifylline, administering 1,200 mg/24 hours through 15 days, was studied in 22 patients (19 m, 3 f) with arteriographically confirmed extensive occlusion in the femoro-popliteal segment, associated with marked intermittent claudication and rest pain of varying severity." | 3.67 | Continuous infusion treatment with pentoxifylline in patients with severe peripheral vascular occlusive disease. ( Angelides, NS, 1986) |
| "In an open clinical trial 14 patients with intermittent claudication caused by an obliteration of the femoral artery received 400 mg pentoxifylline 3 times daily over a period of 6 months." | 3.66 | [The influence of chronic pentroxifylline medication on ergometric and hemodynamic parameters in intermittent claudication (author's transl)]. ( Brock, FE; Nobbe, F; Rudofsky, G; Ulrich, M, 1979) |
| "Pentoxifylline was found both in healthy subjects and patients to significantly increase prostacyclin plasma concentration after i." | 2.66 | Pentoxifylline treatment in patients with occlusive peripheral arterial disease. Circulatory changes and effects on prostaglandin synthesis. ( Boddi, M; Masotti, G; Poggesi, L; Scarti, L; Serneri, GG, 1985) |
| "Pentoxifylline was used in the treatment of 90 patients with atherosclerosis-induced chronic peripheral arterial occlusive disease and diabetic vascular disorders in the lower extremities (clinical Fontaine Stages III and IV) for whom surgical reconstructive treatment was not indicated and who had shown inadequate response to previous therapy." | 1.27 | Clinical investigation of the effects of pentoxifylline in patients with severe peripheral occlusive vascular disease. ( Seige, K; Sternitzky, R, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 58 (98.31) | 18.7374 |
| 1990's | 1 (1.69) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maughan, RJ | 2 |
| Broom, J | 1 |
| Smith, G | 1 |
| Leiper, JB | 1 |
| Ah-See, AK | 1 |
| Engeset, J | 1 |
| Evan-Wong, A | 1 |
| Davidson, RJ | 1 |
| Ambrus, JL | 1 |
| Ambrus, CM | 1 |
| Taheri, SA | 1 |
| Gastpar, H | 1 |
| Reddington, MM | 1 |
| Taheri, P | 1 |
| Kahn, EA | 1 |
| Schattman, GL | 1 |
| Dean, LS | 1 |
| Moore, RH | 1 |
| Di Perri, T | 1 |
| Carandente, O | 1 |
| Vittoria, A | 1 |
| Guerrini, M | 2 |
| Messa, GL | 1 |
| Grandillo, F | 1 |
| Giunta, R | 1 |
| Scognamiglio, G | 1 |
| Tirelli, A | 1 |
| Coppola, L | 1 |
| Torella, R | 1 |
| Benignetti, G | 1 |
| Fabbri, F | 1 |
| Benvenuti, C | 1 |
| Angelkort, B | 5 |
| Kiesewetter, H | 3 |
| Trübestein, G | 2 |
| Trübestein, R | 1 |
| Duong, QD | 1 |
| Accetto, B | 1 |
| Porter, JM | 1 |
| Cutler, BS | 1 |
| Lee, BY | 2 |
| Reich, T | 1 |
| Reichle, FA | 1 |
| Scogin, JT | 1 |
| Strandness, DE | 1 |
| Chmiel, H | 1 |
| Anadere, I | 1 |
| Heimburg, P | 1 |
| Pecchi, S | 1 |
| Rossi, C | 1 |
| Cappelli, R | 1 |
| Pieragalli, D | 1 |
| Acciavatti, A | 1 |
| Pupita, F | 1 |
| Rotatori, P | 1 |
| Frausini, G | 1 |
| Küchle, HJ | 2 |
| Richard, G | 2 |
| Feruglio, FS | 1 |
| Ponte, E | 1 |
| Zaccaria, A | 1 |
| Antonini, M | 1 |
| Marciani, A | 1 |
| Taurino, M | 1 |
| Speziale, F | 1 |
| Spartera, C | 1 |
| Schoop, W | 1 |
| Tannenberg, G | 1 |
| Ehrly, AM | 4 |
| Tonak, J | 1 |
| Knecht, H | 1 |
| Groitl, H | 1 |
| Müller, R | 2 |
| Nobbe, F | 2 |
| von Westphalen, JG | 1 |
| Sondern, W | 1 |
| Leube, G | 1 |
| Koshkin, VM | 1 |
| Adil'khanov, SG | 1 |
| Antonova, NIu | 1 |
| Maurin, N | 1 |
| Boateng, K | 1 |
| Rudofsky, G | 3 |
| Brock, FE | 1 |
| Ulrich, M | 1 |
| Störmer, B | 2 |
| Kleinschmidt, F | 1 |
| Loose, D | 2 |
| Kremer, K | 2 |
| Doppelfeld, E | 1 |
| Völker, D | 1 |
| Mund-Hoym, WD | 1 |
| Lehrach, F | 1 |
| Theis, H | 1 |
| Kleinschmidt, K | 1 |
| Smith, MA | 1 |
| Fish, RC | 1 |
| Schweiger, H | 1 |
| Ortmeier, CJ | 1 |
| Haussler, KF | 2 |
| Künkel, HP | 2 |
| Schneider-May, H | 2 |
| Spengel, F | 2 |
| Symann, O | 2 |
| Werner, HJ | 2 |
| Crowder, JE | 1 |
| Cohn, JB | 1 |
| Savitsky, JP | 2 |
| Morgan, DL | 1 |
| Slywka, J | 1 |
| Cobert, BL | 1 |
| Hryniewicki, SW | 1 |
| Piccirillo, RT | 1 |
| Wilcox, CS | 1 |
| Lindgärde, F | 1 |
| Jelnes, R | 1 |
| Björkman, H | 1 |
| Adielsson, G | 1 |
| Kjellström, T | 1 |
| Palmquist, I | 1 |
| Stavenow, L | 1 |
| von Bary, S | 1 |
| Breddin, K | 1 |
| Diehm, C | 1 |
| Gruss, JD | 1 |
| Heinrich, H | 1 |
| Horsch, S | 1 |
| Kriessmann, A | 1 |
| Maass, U | 1 |
| Martin, M | 1 |
| Manrique, RV | 1 |
| Manrique, V | 1 |
| Chopra, HK | 1 |
| Chopra, KL | 1 |
| Aggarwal, KK | 1 |
| Parashar, SK | 1 |
| Rössner, M | 1 |
| Blume, J | 2 |
| Jung, F | 2 |
| Gerhards, M | 2 |
| Leipnitz, G | 2 |
| Turowski, A | 1 |
| Schmidt, HH | 1 |
| Sternitzky, R | 2 |
| Gleeson, M | 1 |
| Saeger-Lorenz, K | 1 |
| Loyd, RG | 1 |
| Prian, GW | 1 |
| Gomez, H | 1 |
| Laub, J | 1 |
| Mertz, GH | 1 |
| Runge, E | 1 |
| Thiele, P | 1 |
| Perego, MA | 1 |
| Sergio, G | 1 |
| Artale, F | 1 |
| Giunti, P | 1 |
| Danese, C | 1 |
| Angelides, NS | 1 |
| Naide, D | 1 |
| Poggesi, L | 1 |
| Scarti, L | 1 |
| Boddi, M | 1 |
| Masotti, G | 1 |
| Serneri, GG | 1 |
| Berkowitz, P | 1 |
| May, GS | 1 |
| Brobst, J | 1 |
| McCann, WJ | 1 |
| Seige, K | 1 |
4 reviews available for theobromine and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Pentoxifylline -- a biomedical profile.
Topics: Arterial Occlusive Diseases; Blood Viscosity; Brain Ischemia; Cerebrovascular Circulation; Erythrocy | 1979 |
Clinical considerations and treatment of diabetic angiopathy.
Topics: Adult; Arterial Occlusive Diseases; Coronary Disease; Diabetic Angiopathies; Humans; Intermittent Cl | 1979 |
Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease.
Topics: Administration, Oral; Adult; Aged; Arterial Occlusive Diseases; Clinical Trials as Topic; Female; Hu | 1988 |
[Blood rheology in peripheral occlusive disease. Effects of hemodilution and pentoxifylline].
Topics: Arterial Occlusive Diseases; Chronic Disease; Combined Modality Therapy; Hemodilution; Humans; Pento | 1986 |
16 trials available for theobromine and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Comparative evaluation of the effectiveness of buflomedil and pentoxifylline in patients with arterial occlusive disease.
Topics: Adult; Aged; Analysis of Variance; Arterial Occlusive Diseases; Clinical Trials as Topic; Double-Bli | 1981 |
Beneficial hemorheologic therapy of chronic peripheral arterial disorders with pentoxifylline: results of double-blind study versus vasodilator-nylidrin.
Topics: Adult; Aged; Arterial Occlusive Diseases; Chronic Disease; Clinical Trials as Topic; Double-Blind Me | 1982 |
Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients.
Topics: Aged; Arterial Occlusive Diseases; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; E | 1982 |
[Treatment of circulation disorders with pentoxifylline. A double-blind study with Trental].
Topics: Aged; Ambulatory Care; Arterial Occlusive Diseases; Clinical Trials as Topic; Double-Blind Method; F | 1977 |
[Clinical trial of Trental 100 in patients with peripheral arterial occlusive diseases (author's transl)].
Topics: Adult; Aged; Arterial Occlusive Diseases; Blood; Clinical Trials as Topic; Female; Gait; Hemodynamic | 1977 |
[Treatment of arterial diseases with trental 400. Results of a double-blind study].
Topics: Arterial Occlusive Diseases; Double-Blind Method; Drug Evaluation; Humans; Intermittent Claudication | 1978 |
Intravenous treatment of chronic peripheral occlusive arterial disease: a double-blind, placebo-controlled, randomized, multicenter trial of pentoxifylline.
Topics: Adult; Aged; Arterial Occlusive Diseases; Blood Pressure; Clinical Trials as Topic; Double-Blind Met | 1989 |
Efficacy and safety of pentoxifylline in geriatric patients with intermittent claudication.
Topics: Aged; Arterial Occlusive Diseases; Blood Pressure; Chronic Disease; Clinical Trials as Topic; Electr | 1989 |
Conservative drug treatment in patients with moderately severe chronic occlusive peripheral arterial disease. Scandinavian Study Group.
Topics: Aged; Arterial Occlusive Diseases; Blood Pressure; Double-Blind Method; Female; Humans; Intermittent | 1989 |
Intravenous prostaglandin E1 versus pentoxifylline therapy in chronic arterial occlusive disease--a controlled randomised multicenter study.
Topics: Aged; Alprostadil; Arterial Occlusive Diseases; Chronic Disease; Follow-Up Studies; Humans; Multicen | 1989 |
Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease.
Topics: Administration, Oral; Adult; Aged; Arterial Occlusive Diseases; Clinical Trials as Topic; Female; Hu | 1988 |
[Effectiveness of intravenous infusion treatment of peripheral arterial occlusive disease with Trental--results of a multicenter double-blind study].
Topics: Arterial Occlusive Diseases; Clinical Trials as Topic; Double-Blind Method; Humans; Infusions, Intra | 1987 |
[Training by walking and drug therapy of peripheral arterial occlusive disease].
Topics: Aged; Arterial Occlusive Diseases; Clinical Trials as Topic; Combined Modality Therapy; Double-Blind | 1987 |
Influence of pentoxifylline on muscle tissue oxygen tension (pO2) of patients with intermittent claudication before and after pedal ergometer exercise.
Topics: Arterial Occlusive Diseases; Chronic Disease; Clinical Trials as Topic; Exercise Test; Humans; Inter | 1987 |
[Walk training and drug therapy in peripheral arterial occlusive disease. A randomized, prospective, placebo-controlled double-blind study].
Topics: Administration, Oral; Aged; Arterial Occlusive Diseases; Clinical Trials as Topic; Combined Modality | 1987 |
Pentoxifylline treatment in patients with occlusive peripheral arterial disease. Circulatory changes and effects on prostaglandin synthesis.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Arterial Occlusive Diseases; Blood Flow Velocity; Clinical Tria | 1985 |
40 other studies available for theobromine and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Whole blood and red cell ATP content in patients with peripheral vascular disease: the effect of cigarette smoking and oxpentifylline.
Topics: Adenosine Triphosphate; Age Factors; Aged; Arterial Occlusive Diseases; Arteriosclerosis; Erythrocyt | 1984 |
Red cell flexibility and platelet aggregation in patients with chronic obstructive vascular disease (COAD) and study of therapeutic approaches.
Topics: Adult; Aged; Alprostadil; Arterial Occlusive Diseases; Blood Viscosity; Drug Therapy, Combination; F | 1984 |
Studies of the clinical pharmacology and therapeutic efficacy of pentoxifylline in peripheral obstructive arterial disease.
Topics: Alprostadil; Animals; Antifibrinolytic Agents; Arterial Occlusive Diseases; Blood Platelets; Drug Sy | 1984 |
[Effect of pentoxifylline on the dissociation curve of oxyhemoglobin].
Topics: Aged; Arterial Occlusive Diseases; Female; Humans; Male; Oxygen Consumption; Oxyhemoglobins; Pentoxi | 1983 |
[Therapeutic efficacy of pentoxifylline in peripheral artery diseases: its clinical value].
Topics: Aged; Arterial Occlusive Diseases; Blood Viscosity; Female; Humans; Male; Middle Aged; Pentoxifyllin | 1983 |
Influence of risk factors and coagulation phenomena on the fluidity of blood in chronic arterial occlusive disease.
Topics: Adenosine Diphosphate; Arterial Occlusive Diseases; Blood Coagulation; Blood Flow Velocity; Chronic | 1981 |
The influence of I.V. application of pentoxifylline on the viscoelasticity of blood in patients with peripheral vascular disorders.
Topics: Aged; Arterial Occlusive Diseases; Blood Viscosity; Elasticity; Female; Hematocrit; Humans; Injectio | 1981 |
[Effects of pentoxifylline on blood viscosity and peripheral hemodynamics in patients with peripheral occlusive arteriopathies].
Topics: Arterial Occlusive Diseases; Blood Viscosity; Heart Rate; Humans; Muscles; Pentoxifylline; Theobromi | 1981 |
[Clinical pharmacology of vasoactive substances: study on pentoxifylline].
Topics: Aged; Arterial Occlusive Diseases; Drug Evaluation; Female; Heart Rate; Humans; Male; Middle Aged; M | 1981 |
The effect of pentoxifylline on circulatory disturbances of the retina and optic nerve. A report of ten years clinical experience.
Topics: Arterial Occlusive Diseases; Humans; Optic Nerve Diseases; Pentoxifylline; Retinal Artery; Retinal D | 1981 |
[Clinical aspects of hemorrheology in the aged: possibility of prevention and therapy].
Topics: Aged; Arterial Occlusive Diseases; Female; Humans; Intracranial Arteriosclerosis; Leg; Male; Middle | 1981 |
[Clinical and hemodynamic evaluation of the action of pentoxifylline in patients with obstructive arteriopathy of the lower extremities].
Topics: Aged; Arterial Occlusive Diseases; Drug Evaluation; Female; Humans; Leg; Male; Middle Aged; Pentoxif | 1981 |
[Worsening of arterial occlusive diseases by pentoxifylline?].
Topics: Arterial Occlusive Diseases; Humans; Pentoxifylline; Theobromine | 1980 |
[Drug therapy of arterial diseases. A study with Trental 400].
Topics: Adult; Arterial Occlusive Diseases; Blood Pressure; Drug Evaluation; Drug Tolerance; Humans; Male; M | 1980 |
The effect of pentoxifylline on the deformability of erythrocytes and on the muscular oxygen pressure in patients with chronic arterial disease.
Topics: Arterial Occlusive Diseases; Blood Viscosity; Erythrocytes; Humans; Microcirculation; Muscles; Oxyge | 1979 |
[Thrombocytic function, plasmatic blood coagulation and fibrinolysis in chronic arterial occlusive disease. Study with pentoxifilline].
Topics: Adult; Aged; Arterial Occlusive Diseases; Blood Coagulation; Blood Platelets; Chronic Disease; Femal | 1979 |
[Experience with pentoxifylline in chronic obliterative disease of the leg arteries in hospitalized and ambulatory patients].
Topics: Aged; Ambulatory Care; Arterial Occlusive Diseases; Evaluation Studies as Topic; Female; Germany, We | 1979 |
[Peripheral macro-and microcirculatory changes in acute arterial obstruction with papaverine and trental administration].
Topics: Acute Disease; Arterial Occlusive Diseases; Blood Circulation; Drug Evaluation; Embolism; Hemodynami | 1979 |
Influence of pentoxifylline on erythrocyte deformability in peripheral occlusive arterial disease.
Topics: Adult; Aged; Arterial Occlusive Diseases; Erythrocytes; Humans; Middle Aged; Pentoxifylline; Regiona | 1979 |
[Therapy of arterial vascular occlusions of retinal and optic nerve (author's transl)].
Topics: Administration, Oral; Arterial Occlusive Diseases; Humans; Optic Nerve; Pentoxifylline; Retinal Arte | 1979 |
[The influence of chronic pentroxifylline medication on ergometric and hemodynamic parameters in intermittent claudication (author's transl)].
Topics: Arterial Occlusive Diseases; Exercise Therapy; Femoral Artery; Humans; Hyperemia; Intermittent Claud | 1979 |
[Blood rheology in chronic arterial occlusive disease as influenced by vasodilators (author's transl)].
Topics: Arterial Occlusive Diseases; Bencyclane; Blood Proteins; Blood Viscosity; Cycloheptanes; Humans; Mat | 1978 |
[Treatment of chronic arterial occlusive disease. Clinical study with a new galenic preparation of Pentoxifyllin (Trental 400) (author's transl)].
Topics: Aged; Arm; Arterial Occlusive Diseases; Blood Flow Velocity; Chronic Disease; Drug Evaluation; Femal | 1978 |
The effect of pentoxifylline on the flow properties of human blood.
Topics: Arterial Occlusive Diseases; Erythrocyte Count; Erythrocytes; Humans; In Vitro Techniques; Osmolar C | 1978 |
[The treatment of chronic arterial bloodcirculation interference (author's transl)].
Topics: Adult; Aged; Arterial Occlusive Diseases; Cholesterol; Drug Evaluation; Female; Humans; Leg; Leg Ulc | 1978 |
[5 years of clinico-experimental and therapeutic experiences with pentoxifylline].
Topics: Arterial Occlusive Diseases; Cerebrovascular Disorders; Chemical Phenomena; Chemistry; Eye Diseases; | 1977 |
Rheological changes in the blood of patients with chronic arterial occlusive disease after the administration of vasoactive drugs.
Topics: Arterial Occlusive Diseases; Bencyclane; Blood Viscosity; Chronic Disease; Cycloheptanes; Humans; Pe | 1977 |
Improvement of the flow properties of blood: a new therapeutical approach in occlusive arterial disease.
Topics: Adenosine Triphosphate; Ancrod; Arterial Occlusive Diseases; Blood Sedimentation; Blood Viscosity; E | 1976 |
Clinical results of pentoxifylline use in a community peripheral vascular surgical practice.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Female; Humans; Male; Midd | 1990 |
Treatment of chronic occlusive arterial disease with pentoxifylline: changes in clinical and haemodynamic parameters.
Topics: Adult; Aged; Arterial Occlusive Diseases; Blood Pressure; Exercise Test; Female; Hemodynamics; Human | 1989 |
Platelet resistance to prostacyclin. Enhancement of the antiaggregatory effect of prostacyclin by pentoxifylline.
Topics: Adult; Aged; Arterial Occlusive Diseases; Arteriosclerosis; Blood Platelets; Cyclic AMP; Drug Resist | 1987 |
[Treatment of peripheral arterial occlusive disorders with rheologically active measures].
Topics: Arterial Occlusive Diseases; Blood Cell Count; Blood Viscosity; Exercise Test; Female; Hematocrit; H | 1987 |
Adenine nucleotides in erythrocytes from patients with peripheral vascular disease and the effects of oxpentifylline.
Topics: Adenine Nucleotides; Adult; Aged; Arterial Occlusive Diseases; Cells, Cultured; Erythrocyte Deformab | 1987 |
Failure of pentoxifylline for end-stage peripheral vascular disease.
Topics: Aged; Aged, 80 and over; Arterial Occlusive Diseases; Coronary Disease; Humans; Intermittent Claudic | 1987 |
[Whole blood viscosity in patients with acral arterial occlusive diseases and their modification by rheologically active drugs].
Topics: Adult; Arterial Occlusive Diseases; Aspirin; Blood Viscosity; Drug Therapy, Combination; Female; Hum | 1987 |
Haemorrheological improvement by pentoxifylline in patients with peripheral arterial occlusive disease.
Topics: Aged; Arterial Occlusive Diseases; Blood Sedimentation; Blood Viscosity; Female; Fibrinogen; Humans; | 1986 |
Continuous infusion treatment with pentoxifylline in patients with severe peripheral vascular occlusive disease.
Topics: Arterial Occlusive Diseases; Blood Pressure; Female; Femoral Artery; Humans; Infusions, Parenteral; | 1986 |
Drug therapy for peripheral arterial disease.
Topics: Arterial Occlusive Diseases; Calcium Channel Blockers; Dipyridamole; Humans; Pentoxifylline; Theobro | 1986 |
Pentoxifylline treatment of moderate to severe chronic occlusive arterial disease.
Topics: Aged; Arterial Occlusive Diseases; Exercise Test; Humans; Intermittent Claudication; Ischemia; Leg; | 1985 |
Clinical investigation of the effects of pentoxifylline in patients with severe peripheral occlusive vascular disease.
Topics: Adult; Aged; Arterial Occlusive Diseases; Arteriosclerosis; Diabetes Mellitus, Type 1; Diabetes Mell | 1985 |